Psagot Value Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-5,022
Closed -$139K – 88
2024
Q1
$139K Sell
5,022
-39,150
-89% -$1.09M 1.26% 29
2023
Q4
$1.27M Sell
44,172
-1,175
-3% -$35.5K 0.55% 38
2023
Q3
$1.46M Buy
45,347
+22,000
+94% +$778K 0.74% 32
2023
Q2
$847K Sell
23,347
-18,753
-45% -$730K 0.43% 50
2023
Q1
$1.68M Sell
42,100
-58,885
-58% -$2.54M 0.7% 32
2022
Q4
$5.17M Buy
100,985
+731
+0.7% +$35K 1.53% 18
2022
Q3
$4.39M Sell
100,254
-36,763
-27% -$1.79M 1.24% 19
2022
Q2
$7.18M Sell
137,017
-9,754
-7% -$497K 1.68% 11
2022
Q1
$7.6M Buy
146,771
+58,574
+66% +$3.04M 1.67% 14
2021
Q4
$5.21M Buy
88,197
+58,272
+195% +$2.89M 1% 26
2021
Q3
$1.29M Sell
29,925
-82,254
-73% -$3.64M 0.22% 85
2021
Q2
$4.39M Sell
112,179
-807
-0.7% -$31.4K 0.16% 84
2021
Q1
$4.09M Buy
112,986
+33,690
+42% +$1.2M 0.09% 130
2020
Q4
$2.92M Sell
79,296
-34,259
-30% -$1.26M 0.07% 134
2020
Q3
$4.17M Buy
113,555
+10,389
+10% +$384K 0.11% 101
2020
Q2
$3.37M Sell
103,166
-92,275
-47% -$3.3M 0.09% 97
2020
Q1
$6.38M Sell
195,441
-4,650
-2% -$167K 0.26% 73
2019
Q4
$7.84M Buy
200,091
+865
+0.4% +$32.5K 0.27% 81
2019
Q3
$7.16M Sell
199,226
-597
-0.3% -$22.9K 0.29% 79
2019
Q2
$8.66M Buy
199,823
+2,555
+1% +$107K 0.35% 72
2019
Q1
$8.38M Sell
197,268
-3,703
-2% -$156K 0.35% 69
2018
Q4
$8.77M Buy
200,971
+22,875
+13% +$1M 0.4% 64
2018
Q3
$7.85M Buy
178,096
+4,849
+3% +$197K 0.35% 65
2018
Q2
$6.28M Sell
173,247
-683
-0.4% -$24.6K 0.29% 63
2018
Q1
$6.17M Sell
173,930
-9,305
-5% -$337K 0.27% 69
2017
Q4
$6.64M Buy
183,235
+2,351
+1% +$84.5K 0.29% 59
2017
Q3
$6.46M Sell
180,884
-14,422
-7% -$489K 0.27% 60
2017
Q2
$6.56M Buy
195,306
+2,198
+1% +$73.1K 0.28% 57
2017
Q1
$6.61M Sell
193,108
-2,722
-1% -$90.5K 0.28% 55
2016
Q4
$6.36M Buy
195,830
+1,511
+0.8% +$48.6K 0.27% 55
2016
Q3
$6.58M Sell
194,319
-16,981
-8% -$598K 0.28% 54
2016
Q2
$7.44M Sell
211,300
-32,766
-13% -$1.1M 0.32% 48
2016
Q1
$7.23M Sell
244,066
-7,260
-3% -$219K 0.3% 70
2015
Q4
$8.11M Sell
251,326
-34,148
-12% -$1.13M 0.29% 69
2015
Q3
$8.97M Sell
285,474
-252,191
-47% -$8.52M 0.33% 61
2015
Q2
$18M Sell
537,665
-1,228
-0.2% -$42.2K 0.57% 45
2015
Q1
$18.7M Sell
538,893
-168,658
-24% -$5.65M 0.59% 45
2014
Q4
$22M Buy
707,551
+22,930
+3% +$693K 0.75% 38
2014
Q3
$20.2M Buy
684,621
+401,304
+142% +$11.9M 0.68% 44
2014
Q2
$8.41M Sell
283,317
-14,909
-5% -$448K 0.28% 55
2014
Q1
$9.6M Buy
298,226
+11,083
+4% +$348K 0.32% 55
2013
Q4
$8.8M Sell
287,143
-776,491
-73% -$23.8M 0.31% 54
2013
Q3
$30.6M Buy
1,063,634
+40,435
+4% +$1.16M 1.15% 31
2013
Q2
$28.7M Hold
1,023,199
– – 1.21% 26

Other funds holding PFE

Psagot Value Holdings's PFE Position: Q2 2024 in Review

Psagot Value Holdings sold out of Pfizer (PFE) in Q2 2024, closing a stake of 5,022 shares — an estimated $139K sold.

Psagot Value Holdings first reported a position in PFE in Q2 2013 and held it in 44 quarters. The position peaked at $30.6M in Q3 2013. 2,878 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Psagot Value Holdings reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Psagot Value Holdings sold 5,022 Pfizer shares in Q2 2024, an estimated $139K.
  • Psagot Value Holdings first reported a position in Pfizer in Q2 2013 and held it in 44 quarters.
  • Psagot Value Holdings's Pfizer position peaked at $30.6M in Q3 2013.
  • 2,878 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Psagot Value Holdings's 13F filing for Q2 2024.